| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD6340 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.8 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.8 |
| mRNA | azacitidine | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.8 |
| mRNA | BRD-K55473186 | CTRPv2 | pan-cancer | AAC | -0.0088 | 0.9 |
| mRNA | ruxolitinib | CTRPv2 | pan-cancer | AAC | 0.0065 | 0.9 |
| mRNA | leptomycin B | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | IU1 | CTRPv2 | pan-cancer | AAC | -0.0065 | 0.9 |
| mRNA | erastin | CTRPv2 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | selumetinib:navitoclax (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0059 | 0.9 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |